CureSHANK has a singular purpose: To accelerate the development of treatments for Phelan-McDermid syndrome and SHANK-related disorders. Our approach is to identify and fund projects that overcome critical barriers to successful drug development and to coordinate scientific efforts to improve efficiency and speed in the field.
CureSHANK connects funding partners with researchers poised to drive advances in treatments for Shankopathies which are foundational for breakthrough in autism and other neurologic diseases.
CureSHANK connects scientists, investors and companies with one another around a unified strategy to accelerate the development of cures for Shankopathies.
CureSHANK connects patients and families living with a shankopathy disorder to prospective treatments with the highest potential to enhance their quality of life.